Systematic review and meta-analysis on the adverse events of rimonabant treatment: Considerations for its potential use in hepatology-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Systematic review and meta-analysis on the adverse events of rimonabant treatment: Considerations for its potential use in hepatology

Published:2009-10-09 Issue:1 Volume:9 Page:
ISSN:1471-230X
Container-title:BMC Gastroenterology
language:en
Short-container-title:BMC Gastroenterol

Author:

Chavez-Tapia Norberto C,Tellez-Avila Felix I,Bedogni Giorgio,Crocè Lory S,Masutti Flora,Tiribelli Claudio

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

http://link.springer.com/article/10.1186/1471-230X-9-75/fulltext.html

Reference35 articles.

1. Al Snih S, Ottenbacher KJ, Markides KS, Kuo YF, Eschbach K, Goodwin JS: The effect of obesity on disability vs mortality in older Americans. Archives of internal medicine. 2007, 167 (8): 774-780. 10.1001/archinte.167.8.774.

2. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF: Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. The New England journal of medicine. 2006, 355 (8): 763-778. 10.1056/NEJMoa055643.

3. Skilton MR, Moulin P, Serusclat A, Nony P, Bonnet F: A comparison of the NCEP-ATPIII, IDF and AHA/NHLBI metabolic syndrome definitions with relation to early carotid atherosclerosis in subjects with hypercholesterolemia or at risk of CVD: evidence for sex-specific differences. Atherosclerosis. 2007, 190 (2): 416-422. 10.1016/j.atherosclerosis.2006.02.019.

4. Lau DC, Douketis JD, Morrison KM, Hramiak IM, Sharma AM, Ur E: 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. Cmaj. 2007, 176 (8): S1-13.

5. Rubio MA, Gargallo M, Isabel Millan A, Moreno B: Drugs in the treatment of obesity: sibutramine, orlistat and rimonabant. Public health nutrition. 2007, 10 (10A): 1200-1205. 10.1017/S1368980007000717.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Data on Adiponectin from 2010 to 2020: Therapeutic Target and Prognostic Factor for Liver Diseases?;International Journal of Molecular Sciences;2020-07-23

2. Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease;Gastroenterology;2020-07

3. Benefits and Harms in Pivotal Trials of Oral Centrally Acting Antiobesity Medicines: A Systematic Review and Meta-Analysis;Obesity;2018-02-05

4. Diabetes and Non-Alcoholic Fatty Liver Disease;Textbook of Diabetes;2016-12-09

5. Non-alcoholic Fatty Liver Disease in Obesity;Obesity;2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3